We used effects of BC cell‐intrinsic PD‐L1 signals to define a novel treatment strategy to improve cis‐platinum treatment efficacy, which showed a greater effect in PD‐L1‐null versus PD‐L1‐replete BC tumors. This evidence concerns the gene CD274 and breast cancer.